SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Millennium Pharmaceuticals, Inc. (MLNM)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: icanpickem who started this subject1/29/2002 12:42:52 AM
From: mopgcw  Read Replies (2) of 3044
 
Arb on the merger is small:

-Millennium Pharmaceuticals Inc. (MLNM), Cor Therapeutics Inc. (CORR)
Current discount: 8 cents or 0.37%
Acquirer: MLNM
Target: CORR
Shares offered per share: 0.9873
Value of offer per share: $20.57
Total deal value: $1.14 billion
Acquirer share price: $20.83
Target share price: $20.49
Expected closing: First quarter (2/13/02)
Annualized gain: 8.51%
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News